Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actovegin in diabetic polyneuropathy – randomized double‑blind phase 3 trial
2006-004007-19Phase 3Terminated
- Sponsor
- Takeda
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing Actovegin with Placebo (2 arms). Primary endpoint: Average Total Symptom Score (TSS) over treatment period (AUC). Started Oct 2006; status: terminated.
02
Drugs
deproteinized calf blood extract
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2006-004007-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004007-19.